AKT1 and Familial prostate cancer: Axanova et al. showed that AKT inhibitors (API-2 and GSK690693) combined with vitamin D (1 nM, 10 nM, 100 nM) synergistically inhibit the growth of prostate cancer cells (Axanova et al., 2010[2]).